Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

SHBG may be a useful early indicator and treatment target for PCOS.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.